Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 6, 2026
- Moderna reported third-quarter revenue of $1.3 billion and net income of $162 million, raised its 2026 revenue growth outlook to 15%–25%, and expects year-end cash and investments of approximately $8.1 billion to $8.3 billion.
- 10-Q report · filed Nov 6, 2026
- Moderna reported revenue of $1,313 million and net income of $162 million for the quarter ended September 30, 2026. Nine-month net loss was $(1,963) million, and operating activities used $(2,715) million of cash.